Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07545564 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study on Mucosal Specific IgA Immunokinetics After Administration of Nasal Spray Live Attenuated Influenza Vaccine

StatusEnrolling by Invitation
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 22, 2026 (before its estimated April 23, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Mucosal-specific sIgA antibody GMT;Evaluate the achievement of 2-fold and 4-fold increases in the geometric mean titer (GMT) of specific nasal mucosal sIgA antibodies after vaccination
Trial Details
NCT Number NCT07545564
Lead Sponsor Changchun BCHT Biotechnology Co.
Conditions
(from sponsor)		 Influenza
Related terms Influenza, Human
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov